CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.
CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.
复制标题
DOI:
10.1084/jem.191.2.265
复制
发表时间:
2000-01-17
期刊:
影响因子:
--
通讯作者:
Gutierrez-Ramos JC
中科院分区:
文献类型:
--
作者:
Lloyd CM;Delaney T;Nguyen T;Tian J;Martinez-A C;Coyle AJ;Gutierrez-Ramos JC
Isolated peripheral blood CD4 cells from allergic individuals express CC chemokine receptor (CCR)3 and CCR4 after expansion in vitro. In addition, human T helper type 2 (Th2) cells polarized in vitro selectively express CCR3 and CCR4 at certain stages of activation/differentiation and respond preferentially to the ligands eotaxin and monocyte-derived chemokine (MDC). However, controversy arises when the in vivo significance of this distinct expression is discussed. To address the functional role of CCR3/eotaxin and CCR4/MDC during the in vivo recruitment of Th2 cells, we have transferred effector Th cells into naive mice to induce allergic airway disease. Tracking of these cells after repeated antigen challenge has established that both CCR3/eotaxin and CCR4/MDC axes contribute to the recruitment of Th2 cells to the lung, demonstrating the in vivo relevance of the expression of these receptors on Th2 cells. We have shown that involvement of the CCR3/eotaxin pathway is confined to early stages of the response in vivo, whereas repeated antigen stimulation results in the predominant use of the CCR4/MDC pathway. We propose that effector Th2 cells respond to both CCR3/eotaxin and CCR4/MDC pathways initially, but that a progressive increase in CCR4-positive cells results in the predominance of the CCR4/MDC axis in the long-term recruitment of Th2 cells in vivo.
登录
查看更多内容
DOI:
10.1084/jem.190.7.895
发表时间:
1999-10-04
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Coyle AJ;Lloyd C;Tian J;Nguyen T;Erikkson C;Wang L;Ottoson P;Persson P;Delaney T;Lehar S;Lin S;Poisson L;Meisel C;Kamradt T;Bjerke T;Levinson D;Gutierrez-Ramos JC
通讯作者:
Gutierrez-Ramos JC
影响因子:
15.3
作者:
Bonecchi, R;Bianchi, G;Bordignon, P P;D'Ambrosio, D;Lang, R;Borsatti, A;Sozzani, S;Allavena, P;Gray, P A;Mantovani, A;Sinigaglia, F
通讯作者:
Sinigaglia, F
DOI:
10.1084/jem.183.5.2349
发表时间:
1996-05-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Daugherty BL;Siciliano SJ;DeMartino JA;Malkowitz L;Sirotina A;Springer MS
通讯作者:
Springer MS
DOI:
10.1084/jem.184.3.799
发表时间:
1996-09-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1084/jem.169.5.1757
发表时间:
1989-05-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ten RM;Pease LR;McKean DJ;Bell MP;Gleich GJ
通讯作者:
Gleich GJ